Status:
COMPLETED
FLU A+B Nasal Swab Clinical Study
Lead Sponsor:
Response Biomedical Corp.
Conditions:
Influenza
Eligibility:
All Genders
Brief Summary
The purpose of this clinical study is to obtain clearance for the nasal swab sample type by demonstrating the performance characteristics of the FLU A+B Test versus standard laboratory culture for Inf...
Detailed Description
Patients exhibiting symptoms of influenza enrolled in a fashion that confidentiality of all personal health information is maintained. No patient treatment is affected by enrollment in this trial.
Eligibility Criteria
Inclusion
- Male and Female of all age groups
- Patients exhibiting influenza symptoms (i.e., fever, body aches, headaches, cough, sore throat, and other respiratory symptoms) at the time of examination
- Patients must either present with a fever (\>100ºF; \>37.8ºC) at time of examination or have had a fever (\>100ºF; \>37.8ºC) or declare at time of the examination that they had a fever within the previous 3 days prior to the examination
- Must be able to collect sample using the nasal swab sample type
Exclusion
- Patients with no fever at time of examination or within the 3 days prior to examination and/or are currently undergoing treatment (including anti-virals) will be excluded from the study.
Key Trial Info
Start Date :
February 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2008
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT00636662
Start Date
February 1 2008
End Date
May 1 2008
Last Update
March 27 2019
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern University
Chicago, Illinois, United States
2
Washington University / St. Louis Children's Hospital
St Louis, Missouri, United States
3
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
4
Dell Children's Hospital
Austin, Texas, United States